 NEW HAVEN, Conn., June 07, 2021 GLOBE NEWSWIRE -- Arvinas, Inc. Nasdaq: ARVN, a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today joined state and local officials, fellow tenants, and community partners, in a groundbreaking ceremony for 101 College Street, a new 525,000-square-foot-building to be constructed as part of New Havens Downtown Crossing revitalization project. Arvinas will lease three of the 10 floors at 101 College and this space will serve as the Companys headquarters beginning in 2024. 